Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp. (Nasdaq: PBAX) is a blank-check company sponsored by Phoenix Biotech Sponsor LLC and focused on the biotechnology and life sciences sector. The SPAC completed its initial public offering in 2021 and, on January 22, 2024, filed a definitive proxy statement related to a merger or acquisition (Form DEFM14A) with the SEC, indicating that a proposed business combination had advanced to the shareholder-vote stage and that deal terms had been finalized for stockholder review and approval. The filing placed PBAX among a cohort of life-sciences-focused SPACs navigating the post-2021 dealmaking environment. Sign up at SpacDesk to access the full filing history, deal timeline, and sponsor profile for PBAX.